机构:[a]Department of Radiation Oncology, CyberKnife Center, and Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China[b]Department of Abdominal Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, West China Clinical Medicine School, Sichuan University, Chengdu, Sichuan 610041, China四川大学华西医院[c]Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA
This work was supported by the National Natural Science Foundation
of China (No. 81201754), the New Teacher Fund for Doctor
Station, the Ministry of Education (No. 20121202120014), the National
Natural Science Foundation of China (No. 81472797 and No.
81201753), and the Foundation of National Clinical Research Center
of Cancer (No. N14B04).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2015]版:
大类|2 区医学
小类|2 区肿瘤学
最新[2023]版:
大类|1 区医学
小类|2 区肿瘤学
第一作者:
第一作者机构:[a]Department of Radiation Oncology, CyberKnife Center, and Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Mao-Bin Meng,Huan-Huan Wang,Wen-Hao Guo,et al.Targeting pyruvate kinase M2 contributes to radiosensitivity of non-small cell lung cancer cells in vitro and in vivo.[J].Cancer letters.2015,356(2 Pt B):985-93.doi:10.1016/j.canlet.2014.11.016.
APA:
Mao-Bin Meng,Huan-Huan Wang,Wen-Hao Guo,Zhi-Qiang Wu,Xian-Liang Zeng...&Ping Wang.(2015).Targeting pyruvate kinase M2 contributes to radiosensitivity of non-small cell lung cancer cells in vitro and in vivo..Cancer letters,356,(2 Pt B)
MLA:
Mao-Bin Meng,et al."Targeting pyruvate kinase M2 contributes to radiosensitivity of non-small cell lung cancer cells in vitro and in vivo.".Cancer letters 356..2 Pt B(2015):985-93